{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T00:11:40Z","timestamp":1780791100331,"version":"3.54.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordination for the improvement of Higher Education Personnel","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Minas Gerais State Foundation of Support to the Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.cca.2025.120743","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T16:53:05Z","timestamp":1764003185000},"page":"120743","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Altered PCSK9 plasma levels after preeclampsia in the PERLA-Brazil study"],"prefix":"10.1016","volume":"580","author":[{"given":"Isabella Macedo","family":"Costa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tha\u00edse Emilia Moreira","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Let\u00edcia Gon\u00e7alves","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Paula Silva","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thays Santos","family":"da Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e1udia Nat\u00e1lia","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luci Maria","family":"Sant'Ana Dusse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jussara","family":"Mayrink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patr\u00edcia Nessralla","family":"Alpoim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2025.120743_bb0005","doi-asserted-by":"crossref","first-page":"e626","DOI":"10.1016\/S2214-109X(24)00560-6","article-title":"Global and regional causes of maternal deaths 2009\u201320: a WHO systematic analysis","volume":"13","author":"Cresswell","year":"2025","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.cca.2025.120743_bb0010","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1080\/03630242.2025.2489521","article-title":"Preeclampsia beyond pregnancy: investigating the long-term increase in cardiovascular disease and metabolic syndrome (PERLA- Brazil study)","volume":"65","author":"Costa","year":"2025","journal-title":"Women Health"},{"key":"10.1016\/j.cca.2025.120743_bb0015","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1097\/AOG.0000000000003891","article-title":"Gestational hypertension and preeclampsia: ACOG practice bulletin, number 222","volume":"135","author":"ACOG","year":"2020","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.cca.2025.120743_bb0020","doi-asserted-by":"crossref","first-page":"j3078","DOI":"10.1136\/bmj.j3078","article-title":"Risk of post-pregnancy hypertension in women with a history of hypertensive disorders of pregnancy: nationwide cohort study","volume":"358","author":"Behrens","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.cca.2025.120743_bb0025","first-page":"1642","article-title":"Recurrence of pre-eclampsia and the risk of future hypertension and cardiovascular disease: a systematic review and meta-analysis","volume":"125","author":"Brouwers","year":"2018","journal-title":"International Journal of Obstetrics & Gynaecology"},{"key":"10.1016\/j.cca.2025.120743_bb0030","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1136\/heartjnl-2018-313453","article-title":"Future risk of cardiovascular disease risk factors and events in women after a hypertensive disorder of pregnancy","volume":"105","author":"Benschop","year":"2019","journal-title":"Heart"},{"key":"10.1016\/j.cca.2025.120743_bb0035","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.ajpath.2021.04.016","article-title":"Proprotein convertase Subtilisin\/Kexin type 9","volume":"191","author":"Macchi","year":"2021","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cca.2025.120743_bb0040","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000021754","article-title":"Loss-of-function mutation of PCSK9 as a protective factor in the clinical expression of familial hypercholesterolemia","volume":"99","author":"Bayona","year":"2020","journal-title":"Medicine"},{"key":"10.1016\/j.cca.2025.120743_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.placenta.2022.12.008","article-title":"The role of proprotein convertase subtillisin\/kexin type 9 in placental salvage and lipid metabolism in women with preeclampsia","volume":"132","author":"Vaught","year":"2023","journal-title":"Placenta"},{"key":"10.1016\/j.cca.2025.120743_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.repbio.2024.100947","article-title":"Preliminary study on the role of human defensins, interleukins and PCSK9 in early and late preeclampsia","volume":"24","author":"Mennitti","year":"2024","journal-title":"Reprod. Biol."},{"key":"10.1016\/j.cca.2025.120743_bb0055","doi-asserted-by":"crossref","DOI":"10.18502\/ijrm.v21i10.14540","article-title":"Association of proprotein convertase subtilisin\/kexin type 9 protein and oxidative stress indicators in women with preeclampsia: a case-control study","author":"Abbasifard","year":"2023","journal-title":"International Journal of Reproductive BioMedicine (IJRM)"},{"key":"10.1016\/j.cca.2025.120743_bb0060","series-title":"Atualiza\u00e7\u00e3o Da Diretriz Brasileira de Dislipidemias e Preven\u00e7\u00e3o Da Aterosclerose","author":"SOCIEDADE BRASILEIRA DE CARDIOLOGIA","year":"2017"},{"key":"10.1016\/j.cca.2025.120743_bb0065","doi-asserted-by":"crossref","DOI":"10.1161\/HYP.0000000000000087","article-title":"Measurement of blood pressure in humans: a scientific statement from the American Heart Association","volume":"73","author":"Muntner","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.cca.2025.120743_bb0070","series-title":"Guia Pr\u00e1tico de Antropometria Para Adultos: T\u00e9cnicas, \u00cdndices e Indicadores","author":"Sanches","year":"2020"},{"key":"10.1016\/j.cca.2025.120743_bb0075","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.019525","article-title":"Circulating mature PCSK9 level predicts diminished response to statin therapy","volume":"10","author":"Kuyama","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.cca.2025.120743_bb0080","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41392-023-01690-3","article-title":"Targeting proprotein convertase subtilisin\/kexin type 9 (PCSK9): from bench to bedside","volume":"9","author":"Bao","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.cca.2025.120743_bb0085","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.numecd.2019.09.012","article-title":"Platelet function and activation markers in primary hypercholesterolemia treated with anti-PCSK9 monoclonal antibody: a 12-month follow-up","volume":"30","author":"Barale","year":"2020","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"10.1016\/j.cca.2025.120743_bb0090","doi-asserted-by":"crossref","first-page":"5287","DOI":"10.1111\/bph.14931","article-title":"Hyperlipidaemia and cardioprotection: animal models for translational studies","volume":"177","author":"Andreadou","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.cca.2025.120743_bb0095","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s10741-024-10409-7","article-title":"The role of PCSK9 in heart failure and other cardiovascular diseases\u2014mechanisms of action beyond its effect on LDL cholesterol","volume":"29","author":"Dutka","year":"2024","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.cca.2025.120743_bb0100","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1210\/jc.2009-0141","article-title":"Genetic and metabolic determinants of plasma PCSK9 levels","volume":"94","author":"Lakoski","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2025.120743_bb0105","doi-asserted-by":"crossref","first-page":"S337","DOI":"10.1016\/j.dsx.2017.03.012","article-title":"Proprotein convertase subtilisin\/kexin type 9 (PCSK9) and metabolic syndrome components among young adult females","volume":"11","author":"Hasan","year":"2017","journal-title":"Diabetes Metab. Syndr. Clin. Res. Rev."},{"key":"10.1016\/j.cca.2025.120743_bb0110","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1161\/ATVBAHA.110.220988","article-title":"Circulating Proprotein convertase Subtilisin\/Kexin 9 (PCSK9) regulates VLDLR protein and triglyceride accumulation in visceral adipose tissue","volume":"31","author":"Roubtsova","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cca.2025.120743_bb0115","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.005764","article-title":"Circulating levels of Proprotein convertase Subtilisin\/Kexin type 9 and arterial stiffness in a large population sample: data from the Brisighella heart study","volume":"6","author":"Ruscica","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.cca.2025.120743_bb0120","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.atherosclerosis.2016.03.010","article-title":"PCSK9 in relation to coronary plaque inflammation: results of the ATHEROREMO-IVUS study","volume":"248","author":"Cheng","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cca.2025.120743_bb0125","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1194\/jlr.M051326","article-title":"Alirocumab inhibits atherosclerosis, improves the plaque morphology, and enhances the effects of a statin","volume":"55","author":"K\u00fchnast","year":"2014","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.cca.2025.120743_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2020.108717","article-title":"PCSK9: associated with cardiac diseases and their risk factors?","volume":"704","author":"Guo","year":"2021","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.cca.2025.120743_bb0135","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1038\/s41598-018-20425-x","article-title":"PCSK9 induces a pro-inflammatory response in macrophages","volume":"8","author":"Ricci","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cca.2025.120743_bb0140","doi-asserted-by":"crossref","DOI":"10.1161\/ATVBAHA.123.320391","article-title":"Disruption of PCSK9 suppresses inflammation and attenuates abdominal aortic aneurysm formation","volume":"45","author":"Peng","year":"2025","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cca.2025.120743_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.139066","article-title":"Mechanisms underlying the effects of the conditional knockdown of hepatic PCSK9 in attenuating lipopolysaccharide-induced acute liver inflammation","volume":"291","author":"Miao","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.cca.2025.120743_bb0150","article-title":"Conditional knockdown of hepatic PCSK9 ameliorates high-fat diet-induced liver inflammation in mice","volume":"16","author":"Zhang","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cca.2025.120743_bb0155","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1093\/ndt\/gfp038","article-title":"Systemic inflammation, metabolic syndrome and progressive renal disease","volume":"24","author":"Cirillo","year":"2009","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.cca.2025.120743_bb0160","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2023.1130116","article-title":"Setting a stage: inflammation during preeclampsia and postpartum","volume":"14","author":"Herrock","year":"2023","journal-title":"Front. Physiol."},{"key":"10.1016\/j.cca.2025.120743_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2010\/908649","article-title":"Maternal serum levels of TNF-alpha and IL-6 long after delivery in Preeclamptic and normotensive pregnant women","volume":"2010","author":"Vitoratos","year":"2010","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.cca.2025.120743_bb0170","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11883-024-01259-7","article-title":"IL-6 and cardiovascular risk: a narrative review","volume":"27","author":"Mehta","year":"2025","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1016\/j.cca.2025.120743_bb0175","doi-asserted-by":"crossref","first-page":"10669","DOI":"10.2147\/JIR.S531346","article-title":"IL-4 and IL-13 in cardiovascular disease: from immune modulation to therapeutic possibilities \u2013 a narrative review","volume":"18","author":"K\u0131l\u0131\u00e7","year":"2025","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.cca.2025.120743_bb0180","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41392-024-01868-3","article-title":"Targeting cytokine and chemokine signaling pathways for cancer therapy","volume":"9","author":"Yi","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.cca.2025.120743_bb0185","doi-asserted-by":"crossref","first-page":"230","DOI":"10.2174\/1570161120666211227143459","article-title":"Interleukin-10 in the vasculature: pathophysiological implications","volume":"20","author":"de Freitas","year":"2022","journal-title":"Curr. Vasc. Pharmacol."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898125006229?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898125006229?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T18:00:34Z","timestamp":1769796034000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898125006229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":37,"alternative-id":["S0009898125006229"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2025.120743","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Altered PCSK9 plasma levels after preeclampsia in the PERLA-Brazil study","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2025.120743","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"120743"}}